Rolando Pajón

6.8k total citations · 2 hit papers
50 papers, 1.7k citations indexed

About

Rolando Pajón is a scholar working on Microbiology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Rolando Pajón has authored 50 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Microbiology, 29 papers in Epidemiology and 15 papers in Infectious Diseases. Recurrent topics in Rolando Pajón's work include Bacterial Infections and Vaccines (30 papers), Pneumonia and Respiratory Infections (25 papers) and SARS-CoV-2 and COVID-19 Research (11 papers). Rolando Pajón is often cited by papers focused on Bacterial Infections and Vaccines (30 papers), Pneumonia and Respiratory Infections (25 papers) and SARS-CoV-2 and COVID-19 Research (11 papers). Rolando Pajón collaborates with scholars based in United States, Cuba and United Kingdom. Rolando Pajón's co-authors include Dan M. Granoff, Andrew Gorringe, Peter T. Beernink, Brett Leav, Hamilton Bennett, Laurence Chu, Biliana Nestorova, Wenmei Huang, Roderick McPhee and Daniel Yero and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Rolando Pajón

49 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines

2021 222 citations Xiaoying Shen, Haili Tang et al. Cell Host & Microbe profile →
The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials

2023 97 citations Laurence Chu, Rolando Pajón et al. profile →

Peers

Countries citing papers authored by Rolando Pajón

Since Specialization

Citations

This map shows the geographic impact of Rolando Pajón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolando Pajón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolando Pajón more than expected).

Fields of papers citing papers by Rolando Pajón

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rolando Pajón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolando Pajón. The network helps show where Rolando Pajón may publish in the future.

Co-authorship network of co-authors of Rolando Pajón

This figure shows the co-authorship network connecting the top 25 collaborators of Rolando Pajón. A scholar is included among the top collaborators of Rolando Pajón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rolando Pajón. Rolando Pajón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial 2022 ·Nature Medicine ·Laurence Chu, Keith Vrbicky, David C. Montefiori, Wenmei Huang, Biliana Nestorova, Ying Chang, Andrea Carfı́, Darin K. Edwards, Judy Oestreicher, Holly Legault, (unknown), Bethany Girard, Rolando Pajón, Jacqueline M. Miller, Rituparna Das, Brett Leav, Roderick McPhee	56
2	Clinical Utility of Elecsys Anti-SARS-CoV-2 S Assay in COVID-19 Vaccination: An Exploratory Analysis of the mRNA-1273 Phase 1 Trial 2022 ·Frontiers in Immunology ·Simon Jochum, (unknown), (unknown), Veit Peter Grunert, Holly Legault, Udo Eichenlaub, (unknown), Rolando Pajón	39
3	Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation 2021 ·Scientific Reports ·Yunda Huang, Oleg Borisov, Jia Jin Kee, Lindsay N. Carpp, Terri Wrin, (unknown), Marcella Sarzotti‐Kelsoe, Charlene McDanal, Amanda Eaton, Rolando Pajón, John Hural, Christine M. Posavad, Katherine Gill, Shelly Karuna, Lawrence Corey, M. Juliana McElrath, Peter B. Gilbert, Christos J. Petropoulos, David C. Montefiori	20
4	SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines breakdown → 2021 ·Cell Host & Microbe ·Xiaoying Shen, Haili Tang, Charlene McDanal, Kshitij Wagh, Will Fischer, James Theiler, Hyejin Yoon, Dapeng Li, Barton F. Haynes, (unknown), S. Gnanakaran, Nicolas Hengartner, Rolando Pajón, Gale Smith, Gregory M. Glenn, Bette Korber, David C. Montefiori	222
5	A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus 2021 ·Nature Medicine ·Allison August, Husain Attarwala, Sunny Himansu, (unknown), (unknown), Rolando Pajón, Shu Han, Jean‐Michel Lecerf, Joanne E. Tomassini, Marjie Hard, Leon M. Ptaszek, James E. Crowe, Tal Zaks	118
6	A Mutant Library Approach to Identify Improved Meningococcal Factor H Binding Protein Vaccine Antigens 2015 ·PLoS ONE ·(unknown), Raffaella Rossi, Mboto Helen Walter, Rolando Pajón, Peter T. Beernink	15
7	Predicted proteins of Neisseria meningitidis as potential vaccine candidates: from in silico analyses to experimental corroboration 2012 ·SHILAP Revista de lepidopterología ·(unknown), Daniel Yero, (unknown), (unknown), Yasser Perera, (unknown), (unknown), Rolando Pajón	2
8	A Broadly Cross-Reactive Monoclonal Antibody Against an Epitope on the N-terminus of Meningococcal fHbp 2012 ·Scientific Reports ·David M. Vu, Rolando Pajón, Donald C. Reason, Dan M. Granoff	33
9	The Effect of Human Factor H on Immunogenicity of Meningococcal Native Outer Membrane Vesicle Vaccines with Over-Expressed Factor H Binding Protein 2012 ·PLoS Pathogens ·Peter T. Beernink, Jutamas Shaughnessy, Rolando Pajón, (unknown), Sanjay Ram, Dan M. Granoff	40
10	Meningococcal Factor H Binding Proteins in Epidemic Strains from Africa: Implications for Vaccine Development 2011 ·PLoS neglected tropical diseases ·Rolando Pajón, (unknown), Oliver Koeberling, Dominique A. Caugant, Dan M. Granoff	43
11	Diversity of factor H-binding protein in Neisseria meningitidis carriage isolates 2011 ·Vaccine ·Jane W. Marsh, Kathleen A. Shutt, Rolando Pajón, (unknown), Stephen V. Liu, (unknown), Julia A. Kiehlbauch, Thomas A. Clark, David S. Stephens, Kathryn E. Arnold, Robert A. Myers, Leonard W. Mayer, Lee H. Harrison	15
12	Proteomic study via a non-gel based approach of meningococcal outer membrane vesicle vaccine obtained from strain CU385: A road map for discovering new antigens 2009 ·Human Vaccines ·Jeovanis Gil, Lázaro Betancourt, (unknown), Daniel Yero, (unknown), (unknown), (unknown), Rolando Pajón, Aniel Sánchez, Luis Javier González, Gabrìel Padrón, Concepción Campa, Franklin Sotolongo, (unknown), Gerardo Guillén, Luís Herrera, Vladimir Besada	20
13	Identification of new meningococcal serogroup B surface antigens through a systematic analysis of neisserial genomes 2009 ·Vaccine ·Rolando Pajón, Daniel Yero, (unknown), Yanet Climent, (unknown), (unknown), Yasser Perera, Alejandro Llanes, (unknown), (unknown), (unknown), Stephen Taylor, (unknown), Andrew Gorringe	19
14	Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate 2007 ·Vaccine ·(unknown), Daniel Yero, (unknown), (unknown), Yanet Climent, (unknown), (unknown), (unknown), (unknown), Rolando Pajón	29
15	NeisseriaVaccines 2007 2007 ·Expert Review of Vaccines ·Jamie Findlow, Paul Balmer, Daniel Yero, (unknown), Rolando Pajón, Ray Borrow	10
16	Computational identification of beta-barrel outer-membrane proteins in Mycobacterium tuberculosis predicted proteomes as putative vaccine candidates 2006 ·Tuberculosis ·Rolando Pajón, Daniel Yero, Andrey Pereira Lage, Alejandro Llanes, Carlos Borroto	39
17	Outer membrane vesicles of Neisseria lactamica as a potential mucosal adjuvant 2005 ·Vaccine ·(unknown), Karen M. Reddin, Rolando Pajón, Andrew Gorringe	34
18	Effect of P64k Presensitization on Its Efficacy as an Immunological Carrier in Mice 2001 ·Biochemical and Biophysical Research Communications ·Silvia A. González, (unknown), (unknown), Rolando Pajón	1
19	Influence of the length of the P64k protein n-terminus stabilizing peptide on the expression in Escherichia coli of the fused TbpB from Neisseria meningitidis 1998 ·Biotecnología aplicada ·(unknown), (unknown), (unknown), Rolando Pajón, Ricardo Oliveira Silva	2
20	Sequence analysis of the structuraltbpAgene: protein topology and variable regions within neisserial receptors for transferrin iron acquisition 1997 ·Microbial Pathogenesis ·Rolando Pajón, Glay Chinea, (unknown), (unknown), Gerardo Guillén	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact